These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15297217)
1. Early ovarian cancer--time for a rethink on stage? Vergote IB; Amant F Gynecol Oncol; 2004 Aug; 94(2):607; author reply 607-8. PubMed ID: 15297217 [No Abstract] [Full Text] [Related]
2. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678 [TBL] [Abstract][Full Text] [Related]
4. [A case of well differentiated mucinous cystadenocarcinoma of the ovary with intratumoral DNA heterogeneity]. Takahashi Y; Yamade I; Mitsuno N; Yokoe Y; Takenaka A; Noda Y Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jun; 47(6):569-72. PubMed ID: 7608623 [No Abstract] [Full Text] [Related]
5. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study. Verbruggen MB; van Diest PJ; Baak JP; Broeckaert MA; Kenemans P; Verheijen RH Int J Gynecol Pathol; 2009 Jan; 28(1):35-40. PubMed ID: 19047910 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study. Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612 [TBL] [Abstract][Full Text] [Related]
7. Cyclin E overexpression relates to ovarian cancer histology but not to risk factors. Risch HA Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1841; author reply 1841-2. PubMed ID: 18628442 [No Abstract] [Full Text] [Related]
8. Application of new ploidy-related parameters for the diagnosis of ovarian tumours. Korabiowska M; Brinck U; Skubis J; Sattler B; Fischer G Anticancer Res; 2004; 24(6):4191-4. PubMed ID: 15736472 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431 [TBL] [Abstract][Full Text] [Related]
11. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G; Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma]. Novik VI; Gevorkian VA; Maksimov SIa Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446 [TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinomas with neuroendocrine differentiation: Review of five cases referring to immunohistochemical characterization. Yasuda M; Kajiwara H; Osamura YR; Hirasawa T; Muramatsu T; Murakami M; Takagi M; Tadokoro M; Kobayashi Y; Inayama Y; Miyagi E; Nakatani Y J Obstet Gynaecol Res; 2006 Aug; 32(4):387-95. PubMed ID: 16882264 [TBL] [Abstract][Full Text] [Related]
15. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Berchuck A; Iversen ES; Lancaster JM; Pittman J; Luo J; Lee P; Murphy S; Dressman HK; Febbo PG; West M; Nevins JR; Marks JR Clin Cancer Res; 2005 May; 11(10):3686-96. PubMed ID: 15897565 [TBL] [Abstract][Full Text] [Related]
16. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis. Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278 [TBL] [Abstract][Full Text] [Related]
17. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Ann Surg Oncol; 2008 Jul; 15(7):2012-9. PubMed ID: 18437497 [TBL] [Abstract][Full Text] [Related]
18. Proteomic studies of early-stage and advanced ovarian cancer patients. Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221 [TBL] [Abstract][Full Text] [Related]
19. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908 [TBL] [Abstract][Full Text] [Related]
20. A call for prospective studies in early-stage ovarian cancer. Naik R; Ledermann J; Cross PA BJOG; 2010 Nov; 117(12):1441-3. PubMed ID: 20960600 [No Abstract] [Full Text] [Related] [Next] [New Search]